Evermay Wealth Management LLC Acquires 50 Shares of CME Group Inc. $CME

Evermay Wealth Management LLC boosted its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 14.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 400 shares of the financial services provider’s stock after purchasing an additional 50 shares during the period. Evermay Wealth Management LLC’s holdings in CME Group were worth $110,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also added to or reduced their stakes in the business. Accretive Wealth Partners LLC grew its position in CME Group by 1.2% in the second quarter. Accretive Wealth Partners LLC now owns 7,493 shares of the financial services provider’s stock valued at $2,065,000 after purchasing an additional 90 shares in the last quarter. International Assets Investment Management LLC grew its position in CME Group by 3.3% in the second quarter. International Assets Investment Management LLC now owns 2,364 shares of the financial services provider’s stock valued at $652,000 after purchasing an additional 76 shares in the last quarter. DeDora Capital Inc. grew its position in CME Group by 5.1% in the second quarter. DeDora Capital Inc. now owns 1,283 shares of the financial services provider’s stock valued at $354,000 after purchasing an additional 62 shares in the last quarter. TrueMark Investments LLC grew its position in CME Group by 3.8% in the second quarter. TrueMark Investments LLC now owns 26,909 shares of the financial services provider’s stock valued at $7,417,000 after purchasing an additional 993 shares in the last quarter. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al bought a new position in CME Group in the second quarter valued at $96,770,000. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME stock opened at $267.62 on Tuesday. The stock has a market cap of $96.44 billion, a P/E ratio of 25.91, a P/E/G ratio of 6.16 and a beta of 0.41. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The company has a fifty day moving average price of $266.94 and a two-hundred day moving average price of $271.50. CME Group Inc. has a one year low of $213.94 and a one year high of $290.79.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. The firm had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the company posted $2.56 earnings per share. As a group, equities analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 48.40%.

Analysts Set New Price Targets

A number of research analysts recently weighed in on CME shares. Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and raised their target price for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. JPMorgan Chase & Co. increased their price target on shares of CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a research note on Tuesday, October 14th. Jefferies Financial Group cut their price target on shares of CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a research note on Friday, October 10th. Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a research note on Wednesday, October 8th. Finally, TD Cowen increased their price target on shares of CME Group from $281.00 to $288.00 and gave the company a “hold” rating in a research note on Wednesday, October 8th. Seven research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $283.71.

Read Our Latest Analysis on CME Group

Insider Activity at CME Group

In other news, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the sale, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction dated Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the sale, the general counsel owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. This represents a 4.76% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 13,043 shares of company stock worth $3,527,956. 0.30% of the stock is owned by corporate insiders.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.